TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 1 | -2 | -5 | 2 | -1 | 0 | -1 |
| P | %wins | 100 | 0 | 50 | 50 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/3/22 17:49 | 4/29/22 | TPST | Tempest Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Woiwode Thomas | CA | DT | P | 5,000 | 2.36 | 0 | 2,119 | 97 | 4,295 | I | |||||||||||||||
1/4/21 18:02 | 12/30/20 | GRTS | Gritstone Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | P | 5,000 | 3.71 | 0 | 1,348 | 43 | 4,451 | I | |||||||||||||||
10/20/20 17:00 | 10/20/20 | ALGS | Aligos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | P.d | 3,000 | 15.00 | 0 | 200 | 30 | 862 | I | |||||||||||||||
3/3/20 18:57 | 3/3/20 | PASG | Passage Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | DT | P.d | 4,050 | 18.00 | 0 | 225 | 5 | 4,960 | I | |||||||||||||||
12/23/16 18:03 | 10/24/16 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | P.d | 2,254 | 14.00 | 1 | 161 | 27 | 763 | I | 19 | 6 | 3 | -2 | 1 | -3 | -10 | -13 | |||||||
7/25/16 17:09 | 7/25/16 | BOLD | Audentes Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | P.d | 525 | 15.00 | 18 | 35 | 2 | 1,807 | I | 1 | -1 | 0 | 17 | -1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |